Mouse 4T1 Breast Tumor Model

By B. Pulaski, S. Ostrand-Rosenberg. Current Protocols in Immunology, 2000

882 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Oncology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/cfd4a2c36f400525ec2c329fa3f4dc9e0508bd3f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. S. Formenti
2. S. Demaria
3. James P. Allison

Citations in the corpus

• Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. (2010, background): “Vincenzo Bronte (Istituto Oncologico Veneto, Padova, Italy); BALB/c 4T1 mammary carcinoma (11) was provided by Dr.”
• CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer (2004, methodology): “were done as described previously (20).”
• Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. (2005, methodology): “An excellent currently available model of metastatic breast cancer is the BALB/c-derived 4T1 tumor (3).”